Study of ONO-7579 in Patients With Advanced Solid Tumors/ NTRK Gene Fusion Positive Advanced Solid Tumors
Status:
Terminated
Trial end date:
2018-01-30
Target enrollment:
Participant gender:
Summary
This study will determine the safety and maximum tolerated dose of ONO-7579 in patients with
advanced solid tumors, and evaluate efficacy of ONO-7579 in patients with advanced solid
tumors harboring NTRK gene fusions.